What are the treatment options for constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Constipation

Polyethylene glycol (PEG) is the first-line pharmacological treatment for chronic constipation, with a strong recommendation and moderate certainty of evidence, increasing complete spontaneous bowel movements by approximately 2.9 per week. 1

Initial Treatment Approach

First-Line Options

  1. Lifestyle modifications:

    • Optimize toileting habits: attempt defecation 30 minutes after meals, strain no more than 5 minutes 1
    • Increase fluid intake and encourage physical activity 1
    • Maintain adequate dietary fiber intake (though fiber supplements like Metamucil are unlikely to control opioid-induced constipation) 1
  2. Pharmacological treatment:

    • Polyethylene glycol (PEG): 17-34g daily 1
      • Most studied laxative with best results and fewest side effects 2
      • Forms an isotonic solution that increases intestinal content volume 2

Alternative First-Line Options

  • Lactulose: 15-30ml twice daily 1
  • Magnesium hydroxide: Alternative to PEG (avoid in renal impairment) 1
  • Bisacodyl: 10-15mg daily (for short-term or rescue therapy) 1

Specific Treatment for Different Types of Constipation

For Opioid-Induced Constipation (OIC)

  1. Preventive approach:

    • Start prophylactic laxative regimen when initiating opioid therapy 1
    • Use stimulant laxatives (particularly senna) as first-line agents 1
  2. For persistent OIC despite laxative therapy:

    • Peripherally acting μ-opioid receptor antagonists (PAMORAs):
      • Naldemedine: 0.2mg daily (strong recommendation, high-quality evidence) 1
      • Naloxegol: 25mg once daily (strong recommendation, moderate-quality evidence) 1
      • Methylnaltrexone: 0.15mg/kg subcutaneously every other day (conditional recommendation) 1

For Irritable Bowel Syndrome with Constipation (IBS-C)

  • Linaclotide: FDA-approved for IBS-C in adults 3
    • Improves abdominal pain, stool consistency, and complete spontaneous bowel movements 3
    • Effects typically begin within 1 week of treatment 3

Treatment Algorithm Based on Response

  1. Start with PEG (17-34g daily)

  2. If inadequate response after 1-2 weeks:

    • Add or switch to stimulant laxative (bisacodyl 10-15mg daily)
    • Consider combination therapy with soluble fiber (psyllium) and PEG 2
  3. If still inadequate:

    • For OIC: Add PAMORA
    • For chronic idiopathic constipation: Consider linaclotide 3
    • Perform anorectal testing to identify defecatory disorders 1
  4. For refractory cases:

    • Consider surgical options (only in ~5% of cases) such as total colectomy with ileorectal anastomosis for documented slow transit constipation 1

Important Precautions and Contraindications

  • Avoid magnesium-containing laxatives in elderly patients or those with renal impairment (risk of hypermagnesemia) 1
  • Avoid lactulose in patients with neutropenia, thrombocytopenia, paralytic ileus, intestinal obstruction, recent colorectal surgery, or severe colitis 1
  • Avoid liquid paraffin in bed-bound patients (risk of aspiration) 1
  • Avoid bulk laxatives for opioid-induced constipation 1
  • Docusate is ineffective for constipation management in adults 1

Monitoring and Follow-up

  • Goal of therapy: achieve one non-forced bowel movement every 1-2 days 1
  • Monitor for red flags: severe abdominal pain, no bowel movement for >3 days, vomiting, signs of bowel obstruction 1
  • Weekly monitoring of bowel movement frequency and consistency, severity of muscle spasms, mental status 1

Special Considerations

  • Elderly patients require particular attention to medication lists and comorbidities, as they are at higher risk for severe constipation and impaction 1
  • For swallowing difficulties, consider rectal measures (suppositories, enemas) 1
  • Lactulose enema can be used as an alternative to oral laxatives (300 mL lactulose mixed with 700 mL water/saline) 1

References

Guideline

Constipation Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Fiber and macrogol in the therapy of chronic constipation.

Minerva gastroenterologica e dietologica, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.